Original Source(s)
Related Content
CD19 CAR T Therapy Tested in Refractory Rheumatoid Arthritis
Disease activity fell in all six participants in a phase I trial, with three achieving sustained drug-free remission during follow-up
September 8, 2026
-
3 min